You can:
Name | Hydroxycarboxylic acid receptor 2 |
---|---|
Species | Homo sapiens (Human) |
Gene | HCAR2 |
Synonym | G protein-coupled receptor 109A PUMAG Nicotinic acid receptor Nic1 Niacr1 [ Show all ] |
Disease | Type 2 diabetes Hyperlipidaemia Major depressive disorder Cardiovascular disorder Atherosclerosis [ Show all ] |
Length | 363 |
Amino acid sequence | MNRHHLQDHFLEIDKKNCCVFRDDFIVKVLPPVLGLEFIFGLLGNGLALWIFCFHLKSWKSSRIFLFNLAVADFLLIICLPFLMDNYVRRWDWKFGDIPCRLMLFMLAMNRQGSIIFLTVVAVDRYFRVVHPHHALNKISNRTAAIISCLLWGITIGLTVHLLKKKMPIQNGGANLCSSFSICHTFQWHEAMFLLEFFLPLGIILFCSARIIWSLRQRQMDRHAKIKRAITFIMVVAIVFVICFLPSVVVRIRIFWLLHTSGTQNCEVYRSVDLAFFITLSFTYMNSMLDPVVYYFSSPSFPNFFSTLINRCLQRKMTGEPDNNRSTSVELTGDPNKTRGAPEALMANSGEPWSPSYLGPTSP |
UniProt | Q8TDS4 |
Protein Data Bank | N/A |
GPCR-HGmod model | Q8TDS4 |
3D structure model | This predicted structure model is from GPCR-EXP Q8TDS4. |
BioLiP | N/A |
Therapeutic Target Database | T00864 |
ChEMBL | CHEMBL3785 |
IUPHAR | 312 |
DrugBank | BE0000635 |
Name | nicotinic acid |
---|---|
Molecular formula | C6H5NO2 |
IUPAC name | pyridine-3-carboxylic acid |
Molecular weight | 123.111 |
Hydrogen bond acceptor | 3 |
Hydrogen bond donor | 1 |
XlogP | 0.4 |
Synonyms | AJ-08093 Prestwick0_000881 11054-EP2301935A1 ANW-75276 Pyridine-.beta.-carboxylic acid [ Show all ] |
Inchi Key | PVNIIMVLHYAWGP-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9) |
PubChem CID | 938 |
ChEMBL | CHEMBL573 |
IUPHAR | 1588, 1594 |
BindingDB | 23515 |
DrugBank | DB00627 |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
N/A | N/A | DrugBank | |
Activity | 100.0 % | PMID18752940, PMID19592242 | ChEMBL |
Activity | 200.0 % | PMID19524438 | ChEMBL |
EC50 | <1000.0 nM | PMID17804224 | ChEMBL |
EC50 | 8.7 nM | PMID17804224 | BindingDB |
EC50 | 8.71 nM | PMID17804224 | ChEMBL |
EC50 | 26.92 nM | PMID19524438 | ChEMBL |
EC50 | 27.0 nM | PMID20363624, PMID19524438 | BindingDB,ChEMBL |
EC50 | 47.0 nM | PMID25737085 | ChEMBL |
EC50 | 51.0 nM | PMID22435740 | BindingDB,ChEMBL |
EC50 | 63.1 - 1000.0 nM | PMID12522134, PMID12563315, PMID12646212 | IUPHAR |
EC50 | 99.0 nM | PMID24900372 | BindingDB,ChEMBL |
EC50 | 100.0 nM | PMID24900295, PMID22209457 | BindingDB,ChEMBL |
EC50 | 120.0 nM | PMID17358052, PMID17588745 | BindingDB,ChEMBL |
EC50 | 527.0 nM | PMID20184326 | BindingDB,ChEMBL |
EC50 | 580.0 nM | PMID17452318 | BindingDB,ChEMBL |
EC50 | 730.0 nM | PMID26784936 | BindingDB,ChEMBL |
EC50 | 780.0 nM | PMID24900524 | BindingDB,ChEMBL |
EC50 | 1000.0 nM | PMID17994679, PMID20444602, PMID19309152, PMID18029181, PMID18752940, PMID19592242, PMID20452209 | BindingDB,ChEMBL |
EC50 | 1400.0 nM | PMID18760600 | BindingDB,ChEMBL |
Efficacy | 95.0 % | PMID17804224, PMID22435740 | ChEMBL |
Efficacy | 100.0 % | PMID20363624 | ChEMBL |
Fold change | 0.0 - | PMID17994679 | ChEMBL |
IC50 | 130.0 nM | PMID18760600 | BindingDB,ChEMBL |
IC50 | 140.0 nM | PMID17994679, PMID20444602, PMID19307116, PMID20615702, PMID19309152, PMID18029181, PMID19592242, PMID20452209 | BindingDB,ChEMBL |
IC50 | 150.0 nM | PMID18752940 | BindingDB,ChEMBL |
IC50 | 249.0 nM | PMID25737085 | ChEMBL |
IC50 | 67300.0 nM | PMID17452318 | BindingDB,ChEMBL |
Inhibition | 100.0 % | PMID17452318 | ChEMBL |
Kd | 50.1 - 100.0 nM | PMID12522134, PMID12563315, PMID12646212 | IUPHAR |
Ki | 50.0 nM | PMID18665582 | BindingDB,ChEMBL |
Ki | 82.0 nM | PMID20184326 | BindingDB,ChEMBL |
Ki | 104.0 nM | PMID20184326 | BindingDB,ChEMBL |
Ratio | 0.8 - | PMID25737085 | ChEMBL |
Ratio IC50 | 0.0 - | PMID19309152 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417